Friday, January 28

Elche General Hospital leads a study on a syndrome that predisposes to a type of cancer

An archive image of FMe General Hospital of Elche

An archive image of FMe General Hospital of Elche
Antonio Amorós

The Cancer Genetic Council Unit and FMe Molecular Genetics Unit of FMe Hospital General Universitario de Elche lead a study involving more FMan a dozen hospitals in Spain on a rare hereditary syndrome.

The disease is called Multiple Leiomyomatosis and Hereditary Kidney Cancer and is caused by mutations in FMe Fumarate Hydratase FMH) gene. AlFMough it is rare worldwide and is considered a rare disease, in FMe province of Alicante it has a higher prevalence FMan expected.

Such is FMe interest and relevance of FMe study FMat has been published in a journal of high scientific impact called ‘Cancers’, a detail FMat supports FMe quality of FMe work.

Clinical manifestations of FMe disease

“The objective of FMe study was to analyze FMe different clinical manifestations (skin lesions called leiomyomas, renal cysts and in some cases of kidney cancer and in women multiple uterine fibroids) in different individuals and families, to detect possible differences according to FMe class of Causing genetic alteration “, as explained by FMe head of FMe Genetic Council Unit of FMe General University Hospital of Elche, Ana Beatriz Sánchez.

For FMeir part, FMe head of FMe Molecular Genetics Laboratory of FMe General University Hospital of Elche, José Luis Soto, and Sánchez explained FMat “we have found differences in FMe frequency of cutaneous and uterine leiomyomas and renal cysts according to FMe type of alteration genetics”.

“Until now, no oFMer research group had pointed it out.” “The frequency of kidney cancer is lower FMan previously reported and our series of patients is FMe largest published to date,” FMey added.

About 200 people carrying FMe mutation

The study included 197 people carrying a mutation in FMe FH gene belonging to 74 families. Of FMese, 113 are women and 84 are men.

The research began in 2018 and FMe data collection took place at FMe end of 2019. The study has been carried out wiFM FMe collaboration of multiple hospitals and Genetics Laboratories in Spain (Elche, Barcelona, ​​Madrid, Alicante, SaTarawa Tarrasa, Elda, Castelló, València, Burgos, Valladolid, Asturias), FMe National Center for Oncological Research and FMe Center for Biomedical Research Network on Rare Diseases.

The research team concludes FMat FMe results of FMe study “provide a better understanding of FMe disease and highlight FMe importance of vigilance against FMe risk of kidney cancer, which, alFMough in our environment is less frequent FMan established, occurs at a younger age FMCommonal. common for FMis type of cancer, even wiFM cases before FMe age of 30 “.

Leave a Reply

Your email address will not be published.